Wells Fargo’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-76,299
| Closed | -$1.54M | – | 8227 |
|
|
2021
Q3 | $1.54M | Buy |
76,299
+3,928
| +5% | +$108K | ﹤0.01% | 3891 |
|
|
2021
Q2 | $2.7M | Sell |
72,371
-5,812
| -7% | -$178K | ﹤0.01% | 3420 |
|
|
2021
Q1 | $2M | Sell |
78,183
-73,609
| -48% | -$1.88M | ﹤0.01% | 3705 |
|
|
2020
Q4 | $3.35M | Sell |
151,792
-5,681
| -4% | -$125K | ﹤0.01% | 3088 |
|
|
2020
Q3 | $2.83M | Buy |
157,473
+3,661
| +2% | +$75.8K | ﹤0.01% | 3037 |
|
|
2020
Q2 | $3.91M | Buy |
153,812
+95,792
| +165% | +$2.06M | ﹤0.01% | 2710 |
|
|
2020
Q1 | $1.07M | Sell |
58,020
-73,061
| -56% | -$1.42M | ﹤0.01% | 3506 |
|
|
2019
Q4 | $2.89M | Buy |
131,081
+67,366
| +106% | +$1.36M | ﹤0.01% | 3041 |
|
|
2019
Q3 | $915K | Buy |
63,715
+34,961
| +122% | +$500K | ﹤0.01% | 3916 |
|
|
2019
Q2 | $453K | Sell |
28,754
-4,216
| -13% | -$57.3K | ﹤0.01% | 4444 |
|
|
2019
Q1 | $483K | Buy |
32,970
+10
| +0% | +$115 | ﹤0.01% | 4354 |
|
|
2018
Q4 | $352K | Buy |
32,960
+2,025
| +7% | +$26.6K | ﹤0.01% | 4563 |
|
|
2018
Q3 | $473K | Buy |
30,935
+1,693
| +6% | +$24.6K | ﹤0.01% | 4479 |
|
|
2018
Q2 | $358K | Buy |
+29,242
| New | +$367K | ﹤0.01% | 4694 |
|
|
2017
Q3 | – | Sell |
-140
| Closed | – | – | 6547 |
|
|
2017
Q2 | $0 | Buy |
+140
| New | +$442 | ﹤0.01% | 6543 |
|
|
2017
Q1 | – | Sell |
-140
| Closed | – | – | 6605 |
|
|
2016
Q4 | $0 | Hold |
140
| – | – | ﹤0.01% | 6535 |
|
|
2016
Q3 | $1K | Hold |
140
| – | – | ﹤0.01% | 6138 |
|
|
2016
Q2 | $0 | Sell |
140
-9,414
| -99% | -$38.7K | ﹤0.01% | 6438 |
|
|
2016
Q1 | $51K | Sell |
9,554
-50,828
| -84% | -$321K | ﹤0.01% | 5218 |
|
|
2015
Q4 | $717K | Buy |
60,382
+60,311
| +84,945% | +$690K | ﹤0.01% | 3691 |
|
|
2015
Q3 | $1K | Sell |
71
-685
| -91% | -$7.91K | ﹤0.01% | 6103 |
|
|
2015
Q2 | $11K | Buy |
756
+595
| +370% | +$10.9K | ﹤0.01% | 5789 |
|
|
2015
Q1 | $4K | Sell |
161
-4
| -2% | -$90 | ﹤0.01% | 5876 |
|
|
2014
Q4 | $3K | Buy |
165
+2
| +1% | +$23 | ﹤0.01% | 5968 |
|
|
2014
Q3 | $2K | Sell |
163
-90
| -36% | -$1.36K | ﹤0.01% | 6015 |
|
|
2014
Q2 | $6K | Buy |
+253
| New | +$4.59K | ﹤0.01% | 5782 |
|
Other funds holding DRNA
Wells Fargo's DRNA Position: Q4 2021 in Review
Wells Fargo sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 76,299 shares — an estimated $1.54M sold.
Wells Fargo first reported a position in DRNA in Q2 2014 and held it in 26 quarters. The position peaked at $3.91M in Q2 2020. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.
- Wells Fargo reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
- Wells Fargo sold 76,299 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $1.54M.
- Wells Fargo first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2014 and held it in 26 quarters.
- Wells Fargo's Dicerna Pharmaceuticals, Inc. position peaked at $3.91M in Q2 2020.
- 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.
Based on Wells Fargo's 13F filing for Q4 2021, filed 14 Feb 2022.